Human herpes virus-8 and other risk factors for Kaposi's sarcoma in kidney transplant recipients

Transplantation

Volumn 67, Issue 9, 1999, Pages 1236-1242

  Farge, Dominique ^a   Lebbé, Céleste ^a   Marjanovic, Zora ^a   Tuppin, Philippe ^b   Mouquet, Catherine ^d   Peraldi, Marie Noelle ^d   Lang, Philippe ^d   Hiesse, Christian ^d   Antoine, Corinne ^d   Legendre, Christophe ^d   Bedrossian, Jeanine ^a   Gagnadoux, Marie France ^d   Loirat, Chantal ^d   Pellet, Claire ^a   Sheldon, Julie ^c   Golmard, Jean Louis ^b   Agbalika, Felix ^a   Schulz, Thomas F ^c  

^a SAINT LOUIS HOSPITAL   (France)

^b Etablissement Francais des Greffes   (France)

^c Molecular Virology Group   (United Kingdom)

^d Hôpital Saint Louis ^*

Author keywords

[No Author keywords available]

Indexed keywords

LYMPHOBLAST ANTIBODY;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; GRAFT VERSUS HOST REACTION; HERPES; HUMAN; HUMAN HERPESVIRUS 8; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; KAPOSI SARCOMA; KIDNEY TRANSPLANTATION; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; VIRUS DETECTION;

ADULT; AFRICA; ANTIBODIES, VIRAL; ANTILYMPHOCYTE SERUM; DNA, VIRAL; FEMALE; FRANCE; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 8, HUMAN; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MIDDLE EAST; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; RISK FACTORS; SARCOMA, KAPOSI; VIRAL LOAD; VIREMIA;

EID: 0033562519     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199905150-00007     Document Type: Article

References (35)

1. Harwood AR, Osoba D, Horfstader SL, et al. Kaposi's sarcoma in recipients of renal transplants. Am J Med 1979; 67: 759.
2. Qunibi A, Akhtar M, Sheth K, et al. Kaposi's sarcoma: the most common tumor after renal transplantation in Saudi Arabia. Am J Med 1988; 84: 225.
3. Farge D et le Groupe Collaboratif de Recherche en Transplantation de L'ile de France. Kaposi's sarcoma in organ transplant recipients. Eur J Med 1993; 2: 339.
4. Penn I. Kaposi's sarcoma in transplant recipients. Transplantation 1997; 64: 669.
5. Boshoff C, Whitby D, Hatziioannou T, et al. Kaposi's-sarcomaassociated herpesvirus in HIV-negative Kaposi's sarcoma. Lancet 1995; 345: 1043.
6. Buonaguro FM, Tornesello ML, Beth-Giraldo E, et al. Herpesvirus-like DNA sequences detected in endemic, classic, iatrogenic and epidemic Kaposi's sarcoma (KS) biopsies. Int J Cancer 1996; 65: 25.
7. Alkan S, Karcher DS, Ortiz A, et al. Human herpesvirus-8/ Kaposi's sarcoma-associated herpesvirus in organ transplant patients with immunosuppression. Br J Haematol 1997; 96: 412.
8. Moosa MR, Treurnicht FK, Van Rensburg EJ, Schneider JW, Jordaan HF, Engelbrecht S. Detection and subtyping of human herpes virus-8 in renal transplant recipients before and after remission of Kaposi's sarcoma. Transplantation 1998; 66: 214.
9. Kedes DH, Operskalski E, Busch M, et al. The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission. Nature Med 1996; 2: 918.
10. Gao SJ, Kingsley L, Li M, et al. KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nature Med 1996; 2: 925.
11. Simpson GR, Schulz TF, Whitby D, et al. Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet 1996; 349: 1133.
12. Calabro ML, Sheldon J, Favero A, et al. Seroprevalence of Kaposi's sarcoma associated herpesvirus (KSHV/HHV8) in different regions of Italy. J Hum Virol 1998; 1: 207.
13. Whitby D, Luppi M, Barozzi P, Boshoff C, Weiss RA, Torelli G. Human herpesvirus 8 seroprevalence in blood donors and patients with lymphoma from different regions of Italy. J Natl Cancer Inst 1998; 90: 395.
14. Lennette ET, Blackbourn DJ, Levy JA. Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients. Lancet 1996; 348: 858.
15. Mayama S, Cuevas L, Sheldon J, et al. Prevalence and transmission of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in Ugandan children and adolescents. Int J Cancer 1998; 77: 817.
16. Schulz TF. Kaposi's sarcoma-associated herpes virus (human herpes virus 8). J Gen Virol 1998; 79: 1573.
17. Whitby D, Howard MR, Tenant-Flowers M, et al. Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma. Lancet 1995; 346: 799.
18. Al-Sulaiman MH, Mousa DH, Dhar JM, Al-Khader A. Does regressed posttransplantation Kaposi's sarcoma recur following reintroduction of immunosuppression? Am J Nephrol 1992; 12: 384.
19. Montagnino G, Bencini PL, Tarantino A, Caputo R, Ponticelli C. Clinical features and course of Kaposi's sarcoma in kidney transplant recipients: report of 13 cases. Am J Nephrol 1994; 14: 121.
20. Parravicini C, Olsen SJ, Capra M, et al. Risk of Kaposi's sarcoma-associated herpes virus transmission from donor allografts among Italian posttransplant Kaposi's sarcoma patients. Blood 1997; 90: 2826.
21. Regamey R, Yamm M, Wernli M, Thiel G, Cathomas G, Erb P. Transmission of human herpes virus 8 infection from renal transplant donors to recipients. N Engl J Med 1998; 339: 1358.
22. Al-Khader AA, Suleiman M, Al-Hasani M, Haleem A, et al. Posttransplant Kaposi sarcoma: staging as a guide to therapy and prognosis. Nephron 1988; 48: 165.
23. Oksenhendler E, Cazals-Hatem D, Schulz TF, et al. Transient angiolymphoid hyperplasia and Kaposi's sarcoma following primary infection with human herpes virus-8 in a patient with HIV infection. N Engl J Med 1998; 338: 1585.
24. Lebbe C, Agbalika F, De Crémoux P, et al. Detection of human herpesvirus 8 and human T-cell lymphotropic virus type 1 sequences in Kaposi sarcoma. Arch Dermatol 1997; 133: 25.
25. Lebbe C, Blum L, Pellet C, et al. Clinical and biological impact of antiretroviral therapy with protease inhibitors on HIV-related Kaposi's sarcoma. AIDS 1998; 12: F45.
26. Montagnino G, Lorca F, Tarantino A, et al. Cancer incidence in 854 kidney transplant recipients from a single institution: comparison with normal population and with patients under dialytic treatment. Clin Transplant 1996; 10: 461.
27. Lesnoni La Parola I, Masini C, Nanni G, Diociaiuti A, Pannochia N, Cerimele D. Kaposi's sarcoma in renal transplant recipients: experience at the Catholic University in Rome, 1988-1996. Dermatology 1997; 194: 229.
28. Qunibi W, Al-Furayh O, Almeshari K, et al. Serologic association of human herpes virus eight with posttransplant Kaposi's sarcoma in Saudi Arabia. Transplantation 1998; 65: 583.
29. Penn I. Cancer is a long term hazard of immunosuppressive therapy. J Autoimmun 1988; 1: 545.
30. Swinnen LJ, Costanzo-Nordin MR, Fisher SG, et al. Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients. N Engl J Med 1990; 323: 1723.
31. Trattner A, Hodak E, David M, et al. The appearance of Kaposi sarcoma during corticosteroid therapy. Cancer 1993; 72: 1779.
32. Chang Y, Cesarman E, Pessin MS, et al. Identification of herpes virus like DNA sequences in AIDS associated Kaposi's sarcoma. Science 1994; 266: 1865.
33. Siddiqui A. Hepatitis B virus DNA in Kaposi sarcoma. Proc Natl Acad Sci USA 1983; 80: 4861.
34. Gotti E, Remuzzi G. Post-transplant Kaposi's sarcoma. J Am Soc Nephrol 1997; 8: 130.
35. Brambilla L, Boneschi V, Berti E, Corbellino M, Paraviccini C. HHV8 cell-associated viraemia and clinical presentation of Mediterranean Kaposi's sarcoma. Lancet 1996; 347: 1338.